LifeVantage Announces Changes in Its Japan Operations
June 16 2014 - 9:02AM
LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to
helping people achieve healthy living through a combination of a
compelling business opportunity and scientifically validated
products, today announced that it has appointed Jeffery Bean as its
new Managing Director in Japan. Mr. Bean brings 15 years of network
marketing experience to LifeVantage, having worked in management
positions for companies such as VISI, Stemtech International, LIV
International, Synergy Worldwide and Neways, Inc. during his
career. Mr. Bean will be based in the Company's Tokyo office.
Douglas C. Robinson, the Company's President and Chief Executive
Officer said, "Our Japan market is very important to our overall
business. We are excited to have Jeff join our team in Japan
and we believe he will add a great amount of stability and value to
our Japan market. Jeff brings a wealth of experience in the
network marketing industry, particularly in Japan."
In addition, the Company announced that it is working on a
financial arrangement with two of its top distributor leaders in
Japan who are no longer participating in the Company's distributor
activities. The Company believes this arrangement will promote
greater unity among its other distributor leaders in Japan.
About LifeVantage Corporation
LifeVantage Corporation (LFVN), a leader in Nrf2 science and the
maker of Protandim®, the Nrf2 Synergizer® patented dietary
supplement, TrueScienceTM Anti-Aging Skin Care Regimen with
enhanced Nrf2 technologies, and Canine Health, is a science-based
network marketing company. LifeVantage is dedicated to visionary
science that looks to transform wellness and anti-aging internally
and externally with products that dramatically reduce oxidative
stress at the cellular level. The Company was founded in 2003 and
is headquartered in Salt Lake City, Utah.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism and
satisfaction with current prospects, as well as words such as
"believe," "anticipates," "look forward to," "should" and
variations thereof, identify forward-looking statements, but their
absence does not mean that a statement is not forward-looking.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding how appointing a new managing
director in Japan will affect our business in Japan and whether we
will reach a mutual agreement with our distributor leaders and
whether such an agreement will indeed promote the expected unity in
that market. Such forward-looking statements are not guarantees of
performance and the Company's actual results could differ
materially from those contained in such statements. These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others the risk factors discussed
in greater detail in the Company's Annual Report on Form 10-K and
its Quarterly Report on Form 10-Q under the caption "Risk Factors,"
and in other documents filed by the Company from time to time with
the Securities and Exchange Commission. The Company cautions
investors not to place undue reliance on the forward-looking
statements contained in this document. All forward-looking
statements are based on information currently available to the
Company on the date hereof, and the Company undertakes no
obligation to revise or update these forward-looking statements to
reflect events or circumstances after the date of this document,
except as required by law.
CONTACT: Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (310) 954-1105
Partner, ICR, INC
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024